Simon Englund

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Major Depressive Disorder

Top Venues

Multiple sclerosis (Houndmills, Basingstoke, England)

Journal of neurology, neurosurgery, and psychiatry

Annals of neurology

Annals of clinical and translational neurology

This page only lists publications with an associated author ORCID identifier.

Publications

Fredrik Piehl, Peter Alping, Suvi Virtanen, Simon Englund, Joachim Burman, Katharina Fink, Anna Fogdell-Hahn, Martin Gunnarsson, Jan Hillert, Annette M Langer-Gould, Jan Lycke, Johan Mellergård, Petra Nilsson, Tomas Olsson, Jonatan Salzer, Anders Svenningsson, Thomas Frisell
COMBAT-MS: A Population-Based Observational Cohort Study Addressing the Benefit-Risk Balance of Multiple Sclerosis Therapies Compared with Rituximab. Annals of neurology (2024)
Simon Englund, Thomas Frisell, Ying Qu, Kavita Gandhi, Annika Hultén, Marie Kierkegaard, Fredrik Piehl, Elisa Longinetti
Trajectories of self-reported fatigue following initiation of multiple sclerosis disease-modifying therapy. Journal of neurology, neurosurgery, and psychiatry (2024)
Katharina Fink, Agnes Gorczyca, Peter Alping, Simon Englund, Susan Farmand, Annette M Langer-Gould, Fredrik Piehl, Kyla McKay, Thomas Frisell, Neda Razaz
Multiple sclerosis, disease-modifying drugs and risk for adverse perinatal and pregnancy outcomes: Results from a population-based cohort study. Multiple sclerosis (Houndmills, Basingstoke, England) (2023)
Elisa Longinetti, Hannah Bower, Kyla A McKay, Simon Englund, Joachim Burman, Katharina Fink, Anna Fogdell-Hahn, Martin Gunnarsson, Jan Hillert, Annette M Langer-Gould, Jan Lycke, Petra Nilsson, Jonatan Salzer, Anders Svenningsson, Johan Mellergård, Tomas Olsson, Fredrik Piehl, Thomas Frisell
COVID-19 clinical outcomes and DMT of MS patients and population-based controls. Annals of clinical and translational neurology 9 (9) (2022)
Elisa Longinetti, Thomas Frisell, Simon Englund, Johan Reutfors, Fang Fang, Fredrik Piehl
Risk of depression in multiple sclerosis across disease-modifying therapies. Multiple sclerosis (Houndmills, Basingstoke, England) (2021)